|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02373 BEAUTYFARM MED
Nominal 
17.000 0.000 (0.000%) Ranking Overview
Ranking based on 2 research report(s)
Average Ranking 2.50
|
Strong Buy (1)
0
|
Buy (2)
1
|
Hold (3)
1
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2023 | EPS | 94.00 RMB (cts) | |
| Net Profit | 215.66 RMB (MIL) | DPS | 43.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2024 | 240.00 | 105.00 | 41.00 | -- | 243.00 | 237.00 |
| 2025 | 298.00 | 130.00 | 50.00 | -- | 307.00 | 289.00 |
| 2026 | 383.00 | 167.00 | -- | 383.00 | 383.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2024 | 237.00 | 104.00 | 41.00 | CICC | OutPerform | 19.00 | 28/08/2024 | |
| 2024 | 243.00 | 106.00 | -- | MORGAN STANLEY | Equal-weight | 18.60 | 27/08/2024 | |
| 2025 | 289.00 | 126.00 | 50.00 | CICC | -- | -- | 28/08/2024 | |
| 2025 | 307.00 | 134.00 | -- | MORGAN STANLEY | -- | -- | 27/08/2024 | |
| 2026 | 383.00 | 167.00 | -- | MORGAN STANLEY | -- | -- | 27/08/2024 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 24/12/2024 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 115,421 |
| %Change | 3.211% |
| EPS / (LPS) | RMB 0.500 |
| NBV Per Share (¥) | RMB 3.518 |